RAMKHAMHAENG HOSPITAL PUBLIC COMPANY LIMITEDSET: RAM🇹🇭 TH

MD&A · 2024

Overview of Operations

Overview of Operations

Overview of Business Operations and Significant Changes

In 2024, despite the slowdown in the country's economic conditions and the impact of the trade war, the Company continued to focus on stable growth in 2024 by focusing on efficient asset management, prudent investment considerations, and service quality development through the adoption of modern technology. This is in conjunction with improving work processes to manage costs appropriately while maintaining the highest service standards.

The operating results of Ramkhamhaeng Hospital Public Company Limited and its subsidiaries had total operating revenue of Baht 9,960.9 million, an increase of 2%, mainly due to an increase in medical treatment revenue of 4%. Operating profit was Baht 987.9 million, an increase of 40%, due to revenue growth and more efficient cost management. Profit before tax was Baht 884.0 million, a decrease of 48%, and net profit was Baht 692.7 million, a decrease of 51%, mainly due to a 92% decrease in share of profit from associates from the provision for assets of Thonburi Healthcare Group Public Company Limited and a 31% increase in financial costs from investments.


Statement of Financial Position as of 31/12/2024

Assets

The Company had total assets of Baht 41,290 million, an increase of Baht 32 million or 0%.

· Non-current financial assets decreased by Baht 849 million due to the sale of available-for-sale securities.

· Investments in associates increased by Baht 275 million or 2%. There was a net increase in investments during the year, despite the share of loss from Thonburi Healthcare Group Public Company Limited.

· Land, buildings and equipment increased by Baht 586 million from renovations and new building construction to expand the services of subsidiaries.


Liabilities

The Company had total liabilities of Baht 14,350 million, an increase of Baht 313 million or 2%. · Short-term loans decreased by Baht 339 million or 4% (including long-term loans due within 1 year). · Long-term loans increased by Baht 795 million or 39%. Loans increased from investments in an associate, Thonburi Healthcare Group Public Company Limited, and from the construction of buildings of subsidiaries.


Shareholders' Equity

The Company had shareholders' equity of Baht 26,940 million, a decrease of Baht 282 million or -1%.

· Retained earnings decreased by Baht 6 million, which was the net result of recording net profit for the period less dividends paid during the year.

· Other components of equity decreased by Baht 131 million from a decrease in other comprehensive income.


Additional details

Total Revenue

1. Ramkhamhaeng Hospital Public Company Limited and its subsidiaries had total revenue of Baht 9,960.9 million, an increase of Baht 162 million or 2%, an increase from medical treatment and a decrease in sales of medical equipment. This is because in early 2023, the Company delivered a large number of goods according to export purchase orders during the COVID-19 period.

2. Consolidated Financial Statements In 2024, the Company had dividend income from associates of Baht 450.8 million, a decrease of 13.3%, mainly due to dividends from the operating results of Thonburi Healthcare Group Public Company Limited in 2023, which decreased.

3. Financial Activities In 2024, the Company had dividend income from subsidiaries of Baht 152.9 million, a slight increase. Muang Loei Ram Hospital's dividends decreased by 60% due to lower operating results in 2023 and plans to renovate buildings and invest in more efficient medical equipment. Meanwhile, M.I. Calibration System Co., Ltd. increased its dividends due to improved operating results.


Changes in investments in associates and subsidiaries

Investments in and share of profit of associates

The Company had investments in associates - equity method amounting to Baht 8,752.4 million, an increase of approximately Baht 1,000 million, mainly from the purchase of additional shares in Thonburi Healthcare Group Public Company Limited, resulting in the Company's shareholding increasing to 24.59% from 21.85% in 2023.

Investments in associates - equity method amounting to Baht 15,257.0 million. This is a change in equity from the previous year plus increased/decreased investments, plus profit/loss, and less dividends paid during the year. Details of the share of profit from associates in 2024 and 2023 are as follows:


Share of profit from associates for the year 2024

The Company had a share of profit for the year 2024 of Baht 56.8 million, a decrease of Baht 650.9 million or -92%, mainly due to

- The factor of reducing the AdjRW payment rate of social security resulted in a decrease in the proportion of revenue and profit from the hospital group with social security customers.

- Losses from available-for-sale securities were recognized due to market conditions causing prices to decline.

- Losses from hospitals affected by the floods in the north in late 2024.

- The provision for doubtful accounts, assets under development, and leasehold rights, especially the provision of Thonburi Healthcare Group Public Company Limited, resulted in a significant decrease in the Company's share of profit.


Investments in subsidiaries

In 2024, net investment in subsidiaries

- Equity method amounting to Baht 6,926.1 million, an increase of Baht 275.7 million from

- Vajirasirivej Company Limited called for an additional capital increase, resulting in an increase in investment of Baht 35.3 million and

- Ramnakorn Company Limited called for an additional capital increase, resulting in an increase in investment of Baht 240.3 million.

Operating Results & Financial Condition

Operating Results & Profitability

Operating Results and Profitability – Consolidated Financial Statements

Operating Revenue

The company had total operating revenue of 9,960.9 million baht, an increase of 162 million baht or 2%.

• Revenue from medical services was 8,965.3 million baht, an increase of 423 million baht or 5%, due to the growth of medical services, especially Ramkhamhaeng Hospital 2 (Ramnakorn Company Limited), which has continued to grow.

• Revenue from the sale of medical equipment and instruments was 902.3 million baht, a decrease of 190 million baht or -17%, due to a large number of outstanding orders for products during the COVID-19 period from the previous year at the beginning of 2023.


Total Expenses

The company had total expenses of 8,973.0 million baht, a decrease of 46.8 million baht or -1%.

· Medical treatment costs increased in proportion to increased revenue, and the cost of sales of medical equipment and instruments decreased in proportion to decreased revenue.

· Administrative expenses, including credit loss expenses, were 1,441.3 million baht, a decrease of 118 million baht or -8% from more efficient expense management.


Profitability

The company had a net profit of 692.7 million baht, a decrease of 730.1 million baht or -51%, representing a net profit attributable to owners of the parent company of 727.8 million baht, a decrease of 823.4 million baht or -53%.

· Operating profit was 987.9 million baht, an increase of 279.8 million baht or 40% from increased revenue and efficient expense management.

Share of profit from associates decreased by 650.9 million baht, or -92%, mainly due to a share of loss from THG of 434 million baht from the impairment of assets.

· Profit from the sale of investments decreased by 313.9 million baht, or -100%, due to the sale of Mahesak Hospital in 2023.

· Financial costs increased by 100.7 million baht, or 31%, from borrowings for investment.

Liquidity & Capital Adequacy

Key Financial Ratios

1. Cash Cycle (Days)

In 2024, the cash cycle from operating activities improved from 49.49 days in the previous year to 37.65 days, representing a 24.68% improvement. This was attributed to the company's ability to collect receivables faster, from 63.08 days to 56.92 days, manage inventory more efficiently, from 12.21 days to 11.96 days, and extend payment terms with creditors from 42.57 days to 49.38 days.

2. Other Financial Ratios

- The Current Ratio in 2024 was similar to the previous year. Although the figure is only 0.35 times, the company still has investments in market demands that can be sold for cash if necessary.

- ROE and ROA in 2024 were 3.9% and 1.7% respectively, a decrease from 2023. This was mainly due to the share of loss from associates. However, the company is in the process of restructuring its finances, including considering the management of existing assets that are not performing well, have low returns, or are not aligned with the company's long-term strategy, in order to improve return performance.

- The D/E Ratio in 2024 was 0.53 times, similar to the previous year, which is considered to be at a low level.

- Total Asset turnover in 2024 was 0.24 times. The planned management of non-performing assets or assets generating returns below the standard will help improve this figure.

- Gross Profit Margin (%) in 2024 was 23.7%, a significant improvement from the previous year. This was due to better cost management and a reduction in the Social Security Office's revenue criteria for reimbursements in the Vibharam Hospital Group by approximately 200 million baht in 2023.

- EBIT Margin (%) and Net Profit Margin (%) in 2024 were 13.2% and 7.0% respectively. This was mainly due to the share of loss from associates.

Asset Management Capability

Asset Management

1. Trade Receivables The Group's customer base from its business operations consists of cash customers, medium and large corporate customers who are contracted with hospitals, life insurance companies, insurance companies, and the Social Security Office. These companies rarely have payment problems, and the credit term given by the hospital is 2 months. In the case of overdue receivables, there are some minor problems from the group of emergency patients, patients who use the rights of different contractors. It was found that when the hospital issued the invoice, the contractor refused to pay, causing the hospital to have to go back and contact the patient directly for billing, and payment in this part was delayed. In the case of overdue debts exceeding the specified criteria, an allowance for doubtful accounts will be established. In 2014, the Company had total net trade receivables of Baht 865.7 million, an increase of approximately 9%, of which Baht 277.7 million was overdue for more than 3 months, with a net allowance for doubtful accounts of Baht 235.2 million.


2. Inventories In 2014, the Company had total net inventories of Baht 842.4 million, an increase of 2.3%, mainly from an increase in medical equipment, and an allowance for impairment of Baht 107.0 million, a slight increase from the allowance for impairment of long-standing medical equipment. 3. Investments at Fair Value Through Profit or Loss In 2014, the Company sold investments in equity securities at fair value through profit or loss with a total cost of Baht 774.79 million and a gain on sale of investments of Baht 122.68 million. In 2014 and 2013, the Company recognized dividend income of Baht 236.16 million and Baht 261.37 million, respectively. 4. Property, Plant and Equipment In 2014, the Company had net property, plant and equipment of Baht 16,009 million, an increase of 3.8%, an increase in the categories of buildings and structures, medical equipment, equipment and installation, and construction in progress, which was mainly due to the investment of subsidiaries in new construction projects and expansion of existing areas, such as Ramkhamhaeng Hospital 2 (Ramnakorn), Vibharam Laemchabang Hospital, Amata Nakorn Hospital, and Chiangrai Ram Hospital.


3. Investments at Fair Value Through Profit or Loss

In 2014, the Company sold investments in equity securities at fair value through profit or loss with a total cost of Baht 774.79 million and a gain on sale of investments of Baht 122.68 million.

In 2014 and 2013, the Company recognized dividend income of Baht 236.16 million and Baht 261.37 million, respectively.


4. Property, Plant and Equipment

In 2014, the Company had net property, plant and equipment of Baht 16,009 million, an increase of 3.8%, an increase in the categories of buildings and structures, medical equipment, equipment and installation, and construction in progress, which was mainly due to the investment of subsidiaries in new construction projects and expansion of existing areas, such as Ramkhamhaeng Hospital 2 (Ramnakorn), Vibharam Laemchabang Hospital, Amata Nakorn Hospital, and Chiangrai Ram Hospital.

Debt Securities with Financial Ratio Requirements

Debt Securities with Financial Ratio Requirements Issued?

No

Factors That May Affect Financial Condition

Factors or Incidents That May Materially Affect Financial Condition

1) Government policy In the future, if the government has a policy to provide healthcare services to the people as good as or close to private hospitals and facilitates, provides good doctors and nurses to provide services and charges lower medical treatment fees than private hospitals, private hospitals will be affected by this policy. The company has tried to constantly improve its strategies by using external factors as well. If there is price competition in the future, the hospital will have to try to reduce costs in order to be able to set lower selling prices. The hospital has adhered to the quality of good medical treatment and fair prices for 34 years.

2) Changes in the payment criteria for medical services of the Social Security Office, Vibharam Hospital Company Limited, a subsidiary, has revenue from medical treatment from the Social Security project, accounting for 17.8 percent of the company's total revenue (consolidated financial statements). Changes in the main criteria or rates of medical services will affect the company's revenue. However, the company has closely monitored changes in the regulations and criteria of the Social Security Office, as well as controlled medical treatment costs to reduce risks and impacts that may arise from changes in the regulations of the Social Security Office.

3) Industry conditions and competition in the hospital business In the digital age where technology is rapidly advancing, the hospital business is facing intense competition and new challenges. However, with the economic recovery and the increasing trend of health spending, the hospital business still has a lot of growth potential. The group recognizes the importance of adopting technology and innovation to enhance the quality of treatment and services, such as the use of artificial intelligence (AI) in disease diagnosis, the development of digital platforms to facilitate patients, and the use of Big Data in health information analysis.

Projects or R&D Affecting Future Results

-

Contents